Alto Neuroscience, Inc. (NYSE: ANRO) reported Q3 EPS of ($0.62), $0.06 worse than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.